Willow Biosciences Inc. (TSE:WLLW – Get Free Report) fell 16.7% during mid-day trading on Tuesday . The company traded as low as C$0.03 and last traded at C$0.03. 271,669 shares were traded during mid-day trading, a decline of 52% from the average session volume of 561,922 shares. The stock had previously closed at C$0.03.
Willow Biosciences Stock Performance
The company has a debt-to-equity ratio of 131.61, a quick ratio of 19.71 and a current ratio of 0.70. The company has a market capitalization of C$3.61 million, a P/E ratio of -0.42 and a beta of 1.13. The business’s fifty day simple moving average is C$0.06 and its 200-day simple moving average is C$0.08.
Willow Biosciences Company Profile
Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.
See Also
- Five stocks we like better than Willow Biosciences
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Use Stock Screeners to Find Stocks
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Comparing and Trading High PE Ratio Stocks
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
